Details for Patent: 8,802,735
✉ Email this page to a colleague
Which drugs does patent 8,802,735 protect, and when does it expire?
Patent 8,802,735 protects AUBAGIO and is included in one NDA.
Protection for AUBAGIO has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has fifty-nine patent family members in forty countries.
Summary for Patent: 8,802,735
| Title: | (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluormethylphenyl)-amide tablet formulations with improved stability |
| Abstract: | The invention relates to solid pharmaceutical compositions comprising (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide, as well as a process for the preparation of the same, methods of using such compositions to treat subjects suffering from autoimmune diseases in particular systemic lupus erythematosus or chronic graft-versus-host disease, multiple sclerosis or rheumatoid arthritis. |
| Inventor(s): | Hauck; Gerrit (Frankfurt am Main, DE) |
| Assignee: | Sanofi (Paris, FR) |
| Application Number: | 13/422,494 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,802,735 |
|
Patent Claim Types: see list of patent claims | Composition; |
Drugs Protected by US Patent 8,802,735
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sanofi Aventis Us | AUBAGIO | teriflunomide | TABLET;ORAL | 202992-001 | Sep 12, 2012 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Sanofi Aventis Us | AUBAGIO | teriflunomide | TABLET;ORAL | 202992-002 | Sep 12, 2012 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,802,735
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| 09290716 | Sep 18, 2009 | |
International Family Members for US Patent 8,802,735
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 078383 | ⤷ Try a Trial | |||
| Australia | 2010297357 | ⤷ Try a Trial | |||
| Australia | 2013257516 | ⤷ Try a Trial | |||
| Brazil | 112012006184 | ⤷ Try a Trial | |||
| Canada | 2772275 | ⤷ Try a Trial | |||
| Chile | 2012000674 | ⤷ Try a Trial | |||
| Chile | 2015000047 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
